IGFBP7 and acute kidney injury: No significant rise in Cystatin C, serum creatinine or urinary [TIMP-2]*[IGFBP7] was observed in patients with AKI 0/1 at any time indicating that TAS with MHCA per se has no influence on the investigated G1 cell cycle arrest biomarkers or Cystatin C.